J. A. Inciardi, PhD, H. L. Surratt, PhD, Y. Stivers, BA, and T. J. Cicero, PhD, “FDA approvals of generic drugs: Impact on the diversion of opioid analgesics with a potential for abuse”, J of Opioid Management, vol. 5, no. 2, pp. 81–87, Jan. 2018.